SLNCFSilence Therapeutics plcvs its industry peers
A metric-by-metric comparison of Silence Therapeutics plc against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNCFEsta | — | — | — | — | -98.7%#6 | -95.6%#6 | -16292.8%#7 | -230.3%#6 | — | — | — | — |
| SDGR | — | — | — | — | 23.3%#2 | 44.8%#1 | -65.2%#2 | -31.4%#4 | — | — | 33.6%#3 | — |
| SGMT | — | — | — | — | — | -12.0%#3 | -2844.5%#6 | -19.9%#2 | — | — | 28.1%#4 | — |
| SKVI | — | — | — | — | 0.0%#4 | -88.1%#5 | -2481.6%#5 | — | — | — | — | — |
| SLGL | $183M#4 | — | 8.0x#1 | 9.4x#2 | 68.0%#1 | 42.1%#2 | -38.9%#1 | -26.9%#3 | -9.8%#1 | — | 82.5%#2 | — |
| SLN | $2.8B#3 | — | 72.9x#3 | 5019.2x#3 | -98.7%#6 | -95.6%#6 | -16292.8%#7 | -230.3%#6 | — | — | 201.8%#1 | — |
| SMMT | $12.5B#2 | — | 19.9x#2 | — | — | -387.8%#8 | — | -171.4%#5 | — | — | -10.3%#6 | — |
| SMNR | — | — | — | — | — | -3320.4%#10 | — | — | — | — | — | — |
| SMNRW | — | — | — | — | — | -3320.4%#10 | — | — | — | — | — | — |
| SNY | $57.3B#1 | — | — | — | — | — | — | — | — | — | -4.4%#5 | — |
| SPRC | $200994#5 | — | — | 0.2x#1 | -54.6%#5 | -22.7%#4 | -560.2%#4 | — | — | — | -98.1%#7 | — |
| SVA | — | — | — | — | 6.8%#3 | -589.1%#9 | -127.0%#3 | -4.5%#1 | -11.0%#2 | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice